Bioinnovo, comprised of Vetanco and IncuINTA (INTA‘s technical-organizational platform for the development of technological projects) is the first public-private Technology-Based biotechnology Company (TBC) and will be present at the Afrivet Technical Conference 2022 to be held on August 2 and 4 at the Protea Hotel Fire & Ice in Menlyn,…
Bioinnovo has participated in 2021 ISV Annual Virtual Congress by sharing experiences in the development of innovative veterinary vaccines to fight against several diseases, and by introducing the successful case of Vedevax Block, the first subunit recombinant vaccine in the world that has been approved…
A multidisciplinary team, where Bioinnovo SA participates, developed IgY avian antibodies that neutralize the COVID-19 virus. The project “Development and production of critical reagents for diagnosis and treatment of COVID-19: Nanoantibodies, IgY polyclonal antibodies, and recombinant proteins” gathers researchers of INTA, CONICET, the National Institute of Infectious Diseases…
Argentine researchers used two different platforms to neutralize the virus with “nanobodies” derived from llamas and egg immunoglobulins. How do they work? AS A TEAM. WORKING TOGETHER, THE BIOINNOVO WORK GROUP CONTINUES TO GROW. Have no doubts that it is the science that will save…